Ethical issues in clinical trials in developing countries

Area of Science:

• Global Health
• Medical Ethics
• Clinical Trials

Background:

• Vertical transmission trials in developing countries raise significant ethical concerns.
• Key issues include placebo control groups, coercive participation offers, and exploitation of host nations.

Purpose of the Study:

• To examine critical ethical issues in international vertical transmission trials.
• To propose a new standard for the acceptable use of placebo control groups.
• To address concerns regarding coercive offers and exploitation in global health research.

Main Methods:

• Ethical analysis of vertical transmission trials.
• Development of a new ethical standard for placebo control groups.
• Examination of coercion and exploitation in international research contexts.

Main Results:

• The use of placebo control groups in certain contexts is deemed ethically problematic.
• Concerns about the coerciveness of participation offers are found to be largely unfounded.
• Exploitation concerns are better mitigated by focusing on post-trial subject care.

Conclusions:

• A new ethical framework is proposed for the use of placebo controls in developing countries.
• The ethical validity of coercive participation offers requires re-evaluation.
• Ensuring long-term subject welfare is paramount in addressing exploitation concerns in global health research.